Cargando…
Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
Dopamine controls diverse behaviors and their dysregulation contributes to many disorders. Our ability to understand and manipulate the function of dopamine is limited by the heterogenous nature of dopaminergic projections, the diversity of neurons that are regulated by dopamine, the varying distrib...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346604/ https://www.ncbi.nlm.nih.gov/pubmed/34362914 http://dx.doi.org/10.1038/s41467-021-25003-w |
_version_ | 1783734911926009856 |
---|---|
author | Donthamsetti, Prashant Winter, Nils Hoagland, Adam Stanley, Cherise Visel, Meike Lammel, Stephan Trauner, Dirk Isacoff, Ehud |
author_facet | Donthamsetti, Prashant Winter, Nils Hoagland, Adam Stanley, Cherise Visel, Meike Lammel, Stephan Trauner, Dirk Isacoff, Ehud |
author_sort | Donthamsetti, Prashant |
collection | PubMed |
description | Dopamine controls diverse behaviors and their dysregulation contributes to many disorders. Our ability to understand and manipulate the function of dopamine is limited by the heterogenous nature of dopaminergic projections, the diversity of neurons that are regulated by dopamine, the varying distribution of the five dopamine receptors (DARs), and the complex dynamics of dopamine release. In order to improve our ability to specifically modulate distinct DARs, here we develop a photo-pharmacological strategy using a Membrane anchored Photoswitchable orthogonal remotely tethered agonist for the Dopamine receptor (MP-D). Our design selectively targets D1R/D5R receptor subtypes, most potently D1R (MP-D1(ago)), as shown in HEK293T cells. In vivo, we targeted dorsal striatal medium spiny neurons where the photo-activation of MP-D1(ago) increased movement initiation, although further work is required to assess the effects of MP-D1(ago) on neuronal function. Our method combines ligand and cell type-specificity with temporally precise and reversible activation of D1R to control specific aspects of movement. Our results provide a template for analyzing dopamine receptors. |
format | Online Article Text |
id | pubmed-8346604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-83466042021-08-20 Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors Donthamsetti, Prashant Winter, Nils Hoagland, Adam Stanley, Cherise Visel, Meike Lammel, Stephan Trauner, Dirk Isacoff, Ehud Nat Commun Article Dopamine controls diverse behaviors and their dysregulation contributes to many disorders. Our ability to understand and manipulate the function of dopamine is limited by the heterogenous nature of dopaminergic projections, the diversity of neurons that are regulated by dopamine, the varying distribution of the five dopamine receptors (DARs), and the complex dynamics of dopamine release. In order to improve our ability to specifically modulate distinct DARs, here we develop a photo-pharmacological strategy using a Membrane anchored Photoswitchable orthogonal remotely tethered agonist for the Dopamine receptor (MP-D). Our design selectively targets D1R/D5R receptor subtypes, most potently D1R (MP-D1(ago)), as shown in HEK293T cells. In vivo, we targeted dorsal striatal medium spiny neurons where the photo-activation of MP-D1(ago) increased movement initiation, although further work is required to assess the effects of MP-D1(ago) on neuronal function. Our method combines ligand and cell type-specificity with temporally precise and reversible activation of D1R to control specific aspects of movement. Our results provide a template for analyzing dopamine receptors. Nature Publishing Group UK 2021-08-06 /pmc/articles/PMC8346604/ /pubmed/34362914 http://dx.doi.org/10.1038/s41467-021-25003-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Donthamsetti, Prashant Winter, Nils Hoagland, Adam Stanley, Cherise Visel, Meike Lammel, Stephan Trauner, Dirk Isacoff, Ehud Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors |
title | Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors |
title_full | Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors |
title_fullStr | Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors |
title_full_unstemmed | Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors |
title_short | Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors |
title_sort | cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346604/ https://www.ncbi.nlm.nih.gov/pubmed/34362914 http://dx.doi.org/10.1038/s41467-021-25003-w |
work_keys_str_mv | AT donthamsettiprashant cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors AT winternils cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors AT hoaglandadam cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors AT stanleycherise cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors AT viselmeike cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors AT lammelstephan cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors AT traunerdirk cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors AT isacoffehud cellspecificphotoswitchableagonistforreversiblecontrolofendogenousdopaminereceptors |